Angelica Lizcano
Angelica Lizcano has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Cendes
Department of Neurology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil
5 shared publications - Eugen Trinka
Department of Neurology, Neurocritical Care, and Neurorehabilitation, Center for Cognitive Neuroscience, Member of European Reference Network EpiCARE Christian Doppler University Hospital, Paracelsus Medical University Salzburg Austria
4 shared publications - Birgit Frauscher
Department of Neurology, Duke University School of Medicine, Durham, USA
3 shared publications - Ching Soong Khoo
Department of Medicine, Faculty of Medicine Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia
3 shared publications - Jean Paul Vergara Aguilar
Department of Neurology, Fundación Hospital Infantil Universitario de San José, Bogotá 111221, Colombia
3 shared publications - Jo M. Wilmshurst
Department of Paediatric Neurology, Red Cross War Memorial Children's Hospital, Neuroscience Institute University of Cape Town Cape Town South Africa
3 shared publications
Latest Publications
- Open Access
How to Implement a Ketogenic Diet Therapy in Developing Countries: Colombian Consensus on Ketogenic Diet Therapy Use in the Management of Adults with Drug-Resistant Epilepsy
Background/Objectives: Drug-resistant epilepsy affects up to one-third of patients with epilepsy and is associated with higher morbidity, mortality, trauma events, psychosocial challenges, and decline in quality of life. In Latin America, disease burden is high and access to advanced therapies remains limited. Ketogenic Diet Therapy (KDT) has been shown to be beneficial in adults, but its implementation requires standardized protocols and experienced multidisciplinary teams. This study aimed to develop practical, evidence-based recommendations to guide the indication, implementation, and follow-up of KDT in adults with drug-resistant epilepsy through expert consensus in Colombia. Methods: A modified version of the Nominal Group Technique was used to develop, discuss, and vote on management concepts. Clinical questions were structured using the PICO framework. Literature searches were conducted in PubMed and EMBASE for articles published since 2015, and the evidence was integrated with the experience of a multidisciplinary expert panel. Results: Twelve recommendations were issued, covering commercial formulas, induction and follow-up protocols, individualized dietary interventions, safety, diagnostic support, nutritional supplementation, and drug-diet interactions. The consensus highlights the need for interdisciplinary teams, structured education, early adherence strategies, and close follow-up, and the role of enteral emergency formulas in intensive care settings. Conclusions: Evidence around KDT shows it can be implemented safely as an adjunctive treatment for adults with drug-resistant epilepsy and is reasonable to consider following the failure of two adequate antiseizure medications. Structured implementation may reduce seizure frequency, improve quality of life, and reduce the pharmacological burden. Multicenter prospective studies are needed to further assess efficacy, safety, and resource utilization. These recommendations contribute to closing the gap between evidence and clinical practice.
Open AccessHow to Implement a Ketogenic Diet Therapy in Developing Countries: Colombian Consensus on Ketogenic Diet Therapy Use in the Management of Adults with Drug-Resistant Epilepsy
Background/Objectives: Drug-resistant epilepsy affects up to one-third of patients with epilepsy and is associated with higher morbidity, mortality, trauma events, psychosocial challenges, and decline in quality of life. In Latin America, disease burden is high and access to advanced therapies remains limited. Ketogenic Diet Therapy (KDT) has been shown to be beneficial in adults, but its implementation requires standardized protocols and experienced multidisciplinary teams. This study aimed to develop practical, evidence-based recommendations to guide the indication, implementation, and follow-up of KDT in adults with drug-resistant epilepsy through expert consensus in Colombia. Methods: A modified version of the Nominal Group Technique was used to develop, discuss, and vote on management concepts. Clinical questions were structured using the PICO framework. Literature searches were conducted in PubMed and EMBASE for articles published since 2015, and the evidence was integrated with the experience of a multidisciplinary expert panel. Results: Twelve recommendations were issued, covering commercial formulas, induction and follow-up protocols, individualized dietary interventions, safety, diagnostic support, nutritional supplementation, and drug-diet interactions. The consensus highlights the need for interdisciplinary teams, structured education, early adherence strategies, and close follow-up, and the role of enteral emergency formulas in intensive care settings. Conclusions: Evidence around KDT shows it can be implemented safely as an adjunctive treatment for adults with drug-resistant epilepsy and is reasonable to consider following the failure of two adequate antiseizure medications. Structured implementation may reduce seizure frequency, improve quality of life, and reduce the pharmacological burden. Multicenter prospective studies are needed to further assess efficacy, safety, and resource utilization. These recommendations contribute to closing the gap between evidence and clinical practice.
- 8 October 2026
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
A Structured Framework for Translation of the ACNS Standardized Critical Care EEG Terminology Into Spanish
Purpose: The American Clinical Neurophysiology Society (ACNS) Critical Care EEG Terminology provides standardized language for describing electroencephalographic (EEG) patterns in critically ill patients but has not been formally translated into Spanish. We aimed to develop a consensus-based Spanish translation of the ACNS Critical Care EEG Terminology using a multi-phase methodology involving physicians from Spanish-speaking countries. Methods: This qualitative study aimed to establish a standardized Spanish ACNS Critical Care EEG terminology through a three-phase process: Phase 1: Initial iterative translation by 14 Spanish-speaking physicians working in subgroups. Discrepancies were documented for further discussion. Phase 2: Focus groups with specialists practicing in Spanish-speaking countries, guided by qualitative research experts. Sessions explored terminology preferences, implementation challenges, and regional variations. Phase 3: Qualitative analysis and final consensus using a modified Delphi methodology. Ranked choice voting analysis to achieve ≥75% consensus was used and when needed, a two-option runoff determined the final selected term. Results: Forty-five physicians from all Spanish-speaking countries except Nicaragua participated in 10 focus groups to review 25 terms. Seven terms generated two possible Spanish translations, four generated three, five generated four, and nine generated five. A consensus-based Spanish terminology was established, prioritizing semantic fidelity to the ACNS terminology while also accounting for terms already in wide regional use. Examples of final consensus terms included: Generalized Periodic Discharges → Descargas Periódicas Generalizadas (98%, Round 1); Lateralized Rhythmic Delta Activity → Actividad Delta Rítmica Lateralizada (100%, round 1); and Sharp Wave → Onda Aguda (82%, round 1). The outdated term periodic lateralized epileptiform discharges remained widely used because of familiarity among intensivists. Conclusions: This effort provides the first structured Spanish adaptation of the ACNS Critical Care EEG terminology. The resulting lexicon reflects linguistic diversity across regions and supports consistent communication, training, research, and broader adoption of evidence-based continuous EEG practices.
- 8 October 2026
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
A Structured Framework for Translation of the ACNS Standardized Critical Care EEG Terminology Into Spanish
Purpose: The American Clinical Neurophysiology Society (ACNS) Critical Care EEG Terminology provides standardized language for describing electroencephalographic (EEG) patterns in critically ill patients but has not been formally translated into Spanish. We aimed to develop a consensus-based Spanish translation of the ACNS Critical Care EEG Terminology using a multi-phase methodology involving physicians from Spanish-speaking countries. Methods: This qualitative study aimed to establish a standardized Spanish ACNS Critical Care EEG terminology through a three-phase process: Phase 1: Initial iterative translation by 14 Spanish-speaking physicians working in subgroups. Discrepancies were documented for further discussion. Phase 2: Focus groups with specialists practicing in Spanish-speaking countries, guided by qualitative research experts. Sessions explored terminology preferences, implementation challenges, and regional variations. Phase 3: Qualitative analysis and final consensus using a modified Delphi methodology. Ranked choice voting analysis to achieve ≥75% consensus was used and when needed, a two-option runoff determined the final selected term. Results: Forty-five physicians from all Spanish-speaking countries except Nicaragua participated in 10 focus groups to review 25 terms. Seven terms generated two possible Spanish translations, four generated three, five generated four, and nine generated five. A consensus-based Spanish terminology was established, prioritizing semantic fidelity to the ACNS terminology while also accounting for terms already in wide regional use. Examples of final consensus terms included: Generalized Periodic Discharges → Descargas Periódicas Generalizadas (98%, Round 1); Lateralized Rhythmic Delta Activity → Actividad Delta Rítmica Lateralizada (100%, round 1); and Sharp Wave → Onda Aguda (82%, round 1). The outdated term periodic lateralized epileptiform discharges remained widely used because of familiarity among intensivists. Conclusions: This effort provides the first structured Spanish adaptation of the ACNS Critical Care EEG terminology. The resulting lexicon reflects linguistic diversity across regions and supports consistent communication, training, research, and broader adoption of evidence-based continuous EEG practices.
- Open Access
- 13 October 2025
- Published by Wiley in Epileptic Disorders
- Vol. 27 (6) , 1087-1104
A practical guide to the updated seizure classification 2025
This paper provides a practical guide to applying the updated seizure classification in clinical settings. The updated classification, published by the International League Against Epilepsy in 2025, builds on the operational classification introduced in 2017. It aims to enhance clarity, clinical relevance, and consistency in seizure terminology across various healthcare settings. The classification system distinguishes between four main seizure classes: focal, generalized, unknown whether focal or generalized, and unclassified. The basic version allows for application even in resource‐limited or primary care environments, while the expanded version offers detailed semiological descriptors and supports advanced diagnostic and surgical decision‐making. Consciousness, defined through awareness (recall) and responsiveness, is now considered a classifier. The paper also highlights the importance of distinguishing observable from non‐observable features and integrates semiology into the expanded classification with attention to temporal sequence and somatotopic detail. Generalized seizures are categorized into seizure types having a direct impact on syndrome diagnosis and treatment decisions. Epileptic spasms are given special attention because of their unique presentation and the urgency of early intervention, particularly in infants. To support clinical implementation, this paper includes a comprehensive table of semiological descriptors, definitions of generalized seizure types, and a series of real‐world case vignettes illustrating the application of the updated seizure classification. Supplementary figures and videos further support the educational aims of the paper. This practical guide is intended for healthcare professionals managing patients with epilepsy, providing a clear, structured approach to seizure classification that is adaptable to varying levels of clinical expertise and diagnostic resources.
- 13 October 2025
- Published by Wiley in Epileptic Disorders
- Vol. 27 (6) , 1087-1104
Open AccessA practical guide to the updated seizure classification 2025
This paper provides a practical guide to applying the updated seizure classification in clinical settings. The updated classification, published by the International League Against Epilepsy in 2025, builds on the operational classification introduced in 2017. It aims to enhance clarity, clinical relevance, and consistency in seizure terminology across various healthcare settings. The classification system distinguishes between four main seizure classes: focal, generalized, unknown whether focal or generalized, and unclassified. The basic version allows for application even in resource‐limited or primary care environments, while the expanded version offers detailed semiological descriptors and supports advanced diagnostic and surgical decision‐making. Consciousness, defined through awareness (recall) and responsiveness, is now considered a classifier. The paper also highlights the importance of distinguishing observable from non‐observable features and integrates semiology into the expanded classification with attention to temporal sequence and somatotopic detail. Generalized seizures are categorized into seizure types having a direct impact on syndrome diagnosis and treatment decisions. Epileptic spasms are given special attention because of their unique presentation and the urgency of early intervention, particularly in infants. To support clinical implementation, this paper includes a comprehensive table of semiological descriptors, definitions of generalized seizure types, and a series of real‐world case vignettes illustrating the application of the updated seizure classification. Supplementary figures and videos further support the educational aims of the paper. This practical guide is intended for healthcare professionals managing patients with epilepsy, providing a clear, structured approach to seizure classification that is adaptable to varying levels of clinical expertise and diagnostic resources.
- Open Access
- 10 October 2025
- Published by Springer Nature in Clinical Epileptology
- Vol. 38 (4) , 278-295
Revidierte Klassifikation epileptischer Anfälle: Positionspapier der Internationalen Liga gegen Epilepsie
Zusammenfassung: Die Internationale Liga gegen Epilepsie (ILAE) hat die operationale Klassifikation epileptischer Anfälle 2017 auf der Grundlage der damals entwickelten Rahmenbedingungen aktualisiert. In diese Überarbeitung wurden die publizierten Erfahrungen mit der Umsetzung der 2017er-Klassifikation einbezogen. Eine 37 Personen zählende Arbeitsgruppe wurde vom ILAE-Exekutivausschuss eingesetzt. Die internationalen Expertinnen und Experten aus allen ILAE-Regionen wandten ein modifiziertes Delphi-Verfahren an, bei dem für jeden Vorschlag ein Konsens von mehr als zwei Dritteln erforderlich war. Nach Veröffentlichung auf der ILAE-Homepage mit dem Ersuchen, Kommentare zu dem Entwurf einzugeben, ernannte der Exekutivausschuss 7 zusätzliche Sachverständige für die Arbeitsgruppe zur Überarbeitung des Positionspapieres, um die eingegangenen Kommentare zu diskutieren und gegebenenfalls einzubeziehen. Die aktualisierte Klassifikation behält die Hauptklassen von Anfällen bei: fokal, generalisiert, unbekannt (ob fokal oder generalisiert) und nicht klassifiziert. Taxonomische Regeln unterscheiden zwischen Klassifikatoren , die biologische Klassen widerspiegeln und sich direkt auf die klinische Behandlung auswirken, und Deskriptoren , die andere wichtige Anfallsmerkmale angeben. Fokale Anfälle und Anfälle unbekannten Ursprungs werden darüber hinaus nach dem Bewusstseinszustand des Patienten während des Anfalls klassifiziert, je nachdem ob eine Bewusstseinsstörung vorliegt oder nicht. Die Bewertung, ob eine Bewusstseinsstörung vorliegt, wird durch Gewahrsein (engl. „awareness“) und Reaktionsfähigkeit (engl. „responsiveness“) während eines Anfalls und erhaltene Erinnerung (engl. „recall“) nach einem Anfall klinisch operationalisiert. Wenn der Bewusstseinszustand nicht bestimmbar ist, wird der Anfall unter dem übergeordneten Begriff, d. h. der Hauptanfallsklasse (fokaler Anfall oder Anfall unbekannten Ursprungs) klassifiziert. Generalisierte Anfälle werden in Absencen, generalisierte tonisch-klonische Anfälle und andere generalisierte Anfälle eingeteilt, wobei jetzt auch der negative Myoklonus als Anfallstyp beschrieben wird. Anfälle werden in der Grundversion als solche mit oder ohne beobachtbare Manifestationen beschrieben, während eine erweiterte Version die chronologische Abfolge der Anfallssemiologie verwendet. Diese aktualisierte Klassifikation umfasst 4 Hauptklassen und nur noch 21 Anfallstypen (und nicht mehr 63 wie in der 2017 Klassifikation; Anm. d. Übersetzer). Besonderer Wert wurde auf die Übersetzbarkeit in andere Sprachen jenseits von Englisch gelegt. Ziel ist es, eine gemeinsame Sprache für alle im Bereich Epilepsie tätigen Gesundheitsfachkräfte zu schaffen – von ressourcenarmen Gebieten bis hin zu hoch spezialisierten Zentren – und leicht zugängliche Begriffe für Patientinnen und Patienten sowie Betreuungspersonen bereitzustellen.
- 10 October 2025
- Published by Springer Nature in Clinical Epileptology
- Vol. 38 (4) , 278-295
Open AccessRevidierte Klassifikation epileptischer Anfälle: Positionspapier der Internationalen Liga gegen Epilepsie
Zusammenfassung: Die Internationale Liga gegen Epilepsie (ILAE) hat die operationale Klassifikation epileptischer Anfälle 2017 auf der Grundlage der damals entwickelten Rahmenbedingungen aktualisiert. In diese Überarbeitung wurden die publizierten Erfahrungen mit der Umsetzung der 2017er-Klassifikation einbezogen. Eine 37 Personen zählende Arbeitsgruppe wurde vom ILAE-Exekutivausschuss eingesetzt. Die internationalen Expertinnen und Experten aus allen ILAE-Regionen wandten ein modifiziertes Delphi-Verfahren an, bei dem für jeden Vorschlag ein Konsens von mehr als zwei Dritteln erforderlich war. Nach Veröffentlichung auf der ILAE-Homepage mit dem Ersuchen, Kommentare zu dem Entwurf einzugeben, ernannte der Exekutivausschuss 7 zusätzliche Sachverständige für die Arbeitsgruppe zur Überarbeitung des Positionspapieres, um die eingegangenen Kommentare zu diskutieren und gegebenenfalls einzubeziehen. Die aktualisierte Klassifikation behält die Hauptklassen von Anfällen bei: fokal, generalisiert, unbekannt (ob fokal oder generalisiert) und nicht klassifiziert. Taxonomische Regeln unterscheiden zwischen Klassifikatoren , die biologische Klassen widerspiegeln und sich direkt auf die klinische Behandlung auswirken, und Deskriptoren , die andere wichtige Anfallsmerkmale angeben. Fokale Anfälle und Anfälle unbekannten Ursprungs werden darüber hinaus nach dem Bewusstseinszustand des Patienten während des Anfalls klassifiziert, je nachdem ob eine Bewusstseinsstörung vorliegt oder nicht. Die Bewertung, ob eine Bewusstseinsstörung vorliegt, wird durch Gewahrsein (engl. „awareness“) und Reaktionsfähigkeit (engl. „responsiveness“) während eines Anfalls und erhaltene Erinnerung (engl. „recall“) nach einem Anfall klinisch operationalisiert. Wenn der Bewusstseinszustand nicht bestimmbar ist, wird der Anfall unter dem übergeordneten Begriff, d. h. der Hauptanfallsklasse (fokaler Anfall oder Anfall unbekannten Ursprungs) klassifiziert. Generalisierte Anfälle werden in Absencen, generalisierte tonisch-klonische Anfälle und andere generalisierte Anfälle eingeteilt, wobei jetzt auch der negative Myoklonus als Anfallstyp beschrieben wird. Anfälle werden in der Grundversion als solche mit oder ohne beobachtbare Manifestationen beschrieben, während eine erweiterte Version die chronologische Abfolge der Anfallssemiologie verwendet. Diese aktualisierte Klassifikation umfasst 4 Hauptklassen und nur noch 21 Anfallstypen (und nicht mehr 63 wie in der 2017 Klassifikation; Anm. d. Übersetzer). Besonderer Wert wurde auf die Übersetzbarkeit in andere Sprachen jenseits von Englisch gelegt. Ziel ist es, eine gemeinsame Sprache für alle im Bereich Epilepsie tätigen Gesundheitsfachkräfte zu schaffen – von ressourcenarmen Gebieten bis hin zu hoch spezialisierten Zentren – und leicht zugängliche Begriffe für Patientinnen und Patienten sowie Betreuungspersonen bereitzustellen.
- Open Access
- 15 July 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (5) , 1373-1387
Neuronal surface and intracellular antibody testing in patients with long‐term epilepsy
Objective: We aimed to investigate the frequency of neuronal surface and intracellular antibodies in individuals with long‐term epilepsy and the associated clinical and laboratory characteristics. Methods: We tested sera from 223 patients with epilepsy without signs of autoimmune encephalitis and 12 patients with epilepsy and a subacute onset of additional neurological symptoms. All had epilepsy lasting at least one year. We compared clinical and laboratory characteristics between those with and without antibodies. Additionally, we assessed the ACES and APE scores, and ONES checklist for identifying patients with antibodies. Results: Only one of 223 patients with epilepsy and no autoimmune encephalitis signs (0.4%) had antibodies, presenting with drug‐resistant mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE‐HS) and GAD antibodies. She had no improvement after surgical treatment (Engel IV). Of the 12 patients with subacute onset of additional neurological symptoms, four (33.3%) had antibodies: two anti‐GAD, one anti‐LGI1, and one anti‐Hu. Antibody‐positive patients showed later epilepsy onset, had more seizure frequency fluctuations, cutaneous drug reactions, and electrographic seizures compared to antibody‐negative patients. All of them had TLE, and anti‐GAD cases had refractory unilateral MTLE‐HS, musicogenic seizures, and temporal hypermetabolism on interictal FDG‐PET. The ONES checklist had the highest sensitivity and specificity to identify patients with antibodies. Significance: All patients with long‐term epilepsy and neuronal antibodies had TLE, with 60% exhibiting MTLE‐HS associated with GAD antibodies. Neuronal antibodies were rarely detected (0.4%) among patients with isolated long‐term epilepsy, but when present, they were associated with specific clinical and laboratory features. Plain Language Summary: Neuronal antibodies are biological markers of autoimmune encephalitis, a condition that causes sudden and rapidly worsening cognitive decline, changes in mental state, and psychiatric symptoms, often accompanied by seizures and other neurological issues. In our study, we investigated how often these antibodies appear in patients with isolated long‐term epilepsy and what clinical or laboratory characteristics are associated with them. We found neuronal antibodies only in patients with temporal lobe epilepsy. These antibodies were rare (0.4%) among patients with long‐term epilepsy alone and were linked to specific clinical and laboratory features.
- 15 July 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (5) , 1373-1387
Open AccessNeuronal surface and intracellular antibody testing in patients with long‐term epilepsy
Objective: We aimed to investigate the frequency of neuronal surface and intracellular antibodies in individuals with long‐term epilepsy and the associated clinical and laboratory characteristics. Methods: We tested sera from 223 patients with epilepsy without signs of autoimmune encephalitis and 12 patients with epilepsy and a subacute onset of additional neurological symptoms. All had epilepsy lasting at least one year. We compared clinical and laboratory characteristics between those with and without antibodies. Additionally, we assessed the ACES and APE scores, and ONES checklist for identifying patients with antibodies. Results: Only one of 223 patients with epilepsy and no autoimmune encephalitis signs (0.4%) had antibodies, presenting with drug‐resistant mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE‐HS) and GAD antibodies. She had no improvement after surgical treatment (Engel IV). Of the 12 patients with subacute onset of additional neurological symptoms, four (33.3%) had antibodies: two anti‐GAD, one anti‐LGI1, and one anti‐Hu. Antibody‐positive patients showed later epilepsy onset, had more seizure frequency fluctuations, cutaneous drug reactions, and electrographic seizures compared to antibody‐negative patients. All of them had TLE, and anti‐GAD cases had refractory unilateral MTLE‐HS, musicogenic seizures, and temporal hypermetabolism on interictal FDG‐PET. The ONES checklist had the highest sensitivity and specificity to identify patients with antibodies. Significance: All patients with long‐term epilepsy and neuronal antibodies had TLE, with 60% exhibiting MTLE‐HS associated with GAD antibodies. Neuronal antibodies were rarely detected (0.4%) among patients with isolated long‐term epilepsy, but when present, they were associated with specific clinical and laboratory features. Plain Language Summary: Neuronal antibodies are biological markers of autoimmune encephalitis, a condition that causes sudden and rapidly worsening cognitive decline, changes in mental state, and psychiatric symptoms, often accompanied by seizures and other neurological issues. In our study, we investigated how often these antibodies appear in patients with isolated long‐term epilepsy and what clinical or laboratory characteristics are associated with them. We found neuronal antibodies only in patients with temporal lobe epilepsy. These antibodies were rare (0.4%) among patients with long‐term epilepsy alone and were linked to specific clinical and laboratory features.
- Open Access
- 2 July 2025
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 41 (3)
Recomendaciones para el manejo de las crisis epilépticas urgentes y el estado epiléptico: consenso colombiano de expertos
Introducción: las crisis epilépticas aisladas de alto riesgo, el clúster de crisis y el estado epiléptico, se engloban bajo el concepto de crisis epilépticas urgentes. Esta situación clínica es muy prevalente y tiene un impacto negativo en la morbimortalidad de los pacientes. El tratamiento rápido y adecuado es uno de los factores pronósticos más importantes para mejorar el desenlace funcional de estos pacientes. Materiales y métodos: se formó un grupo de trabajo con 11 expertos en epilepsia y medicina de emergencias, guiado por un experto internacional. Se elaboraron recomendaciones sobre el manejo de las crisis epilépticas urgentes, basadas en la información obtenida por una revisión sistemática de la literatura (periodo 2014-2024). Los hallazgos se evaluaron mediante la metodología Delphi, estableciendo un umbral de aceptación con una mediana de 9 (rango intercuartil <1,5) y permitiendo a los miembros votar y discutir las recomendaciones. Una reunión académica facilitó un análisis detallado y la elaboración del consenso final. Resultados: los resultados se agruparon en seis subtipos de recomendaciones que abarcaron: definición de conceptos, tratamiento inicial de las crisis epilépticas urgentes, tratamiento de las crisis epilépticas aisladas de alto riesgo, tratamiento de clúster de crisis, tratamiento del estado epiléptico motor y otras recomendaciones. Conclusiones: en pacientes con crisis epilépticas urgentes, la variable que más influyó en el pronóstico funcional fue la velocidad en la instauración del tratamiento, por lo anterior, el consenso de expertos recomendó ofrecer un tratamiento rápido y organizado. Este tratamiento se debe individualizar a partir del escenario clínico y las comorbilidades específicas de cada paciente.
- 2 July 2025
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 41 (3)
Open AccessRecomendaciones para el manejo de las crisis epilépticas urgentes y el estado epiléptico: consenso colombiano de expertos
Introducción: las crisis epilépticas aisladas de alto riesgo, el clúster de crisis y el estado epiléptico, se engloban bajo el concepto de crisis epilépticas urgentes. Esta situación clínica es muy prevalente y tiene un impacto negativo en la morbimortalidad de los pacientes. El tratamiento rápido y adecuado es uno de los factores pronósticos más importantes para mejorar el desenlace funcional de estos pacientes. Materiales y métodos: se formó un grupo de trabajo con 11 expertos en epilepsia y medicina de emergencias, guiado por un experto internacional. Se elaboraron recomendaciones sobre el manejo de las crisis epilépticas urgentes, basadas en la información obtenida por una revisión sistemática de la literatura (periodo 2014-2024). Los hallazgos se evaluaron mediante la metodología Delphi, estableciendo un umbral de aceptación con una mediana de 9 (rango intercuartil <1,5) y permitiendo a los miembros votar y discutir las recomendaciones. Una reunión académica facilitó un análisis detallado y la elaboración del consenso final. Resultados: los resultados se agruparon en seis subtipos de recomendaciones que abarcaron: definición de conceptos, tratamiento inicial de las crisis epilépticas urgentes, tratamiento de las crisis epilépticas aisladas de alto riesgo, tratamiento de clúster de crisis, tratamiento del estado epiléptico motor y otras recomendaciones. Conclusiones: en pacientes con crisis epilépticas urgentes, la variable que más influyó en el pronóstico funcional fue la velocidad en la instauración del tratamiento, por lo anterior, el consenso de expertos recomendó ofrecer un tratamiento rápido y organizado. Este tratamiento se debe individualizar a partir del escenario clínico y las comorbilidades específicas de cada paciente.
- Top Cited PapersOpen Access
Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy
The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework established in 2017. This revision, informed by the implementation experience, involved a working group appointed by the ILAE Executive Committee. Comprising 37 members from all ILAE regions, the group utilized a modified Delphi process, requiring a consensus threshold of more than two thirds for any proposal. Following public comments, the Executive Committee appointed seven additional experts to the revision task force to address and incorporate the issues raised, as appropriate. The updated classification maintains four main seizure classes: Focal, Generalized, Unknown (whether focal or generalized), and Unclassified. Taxonomic rules distinguish classifiers, which are considered to reflect biological classes and directly impact clinical management, from descriptors, which indicate other important seizure characteristics. Focal seizures and those of unknown origin are further classified by the patient's state of consciousness (impaired or preserved) during the seizure, defined operationally through clinical assessment of awareness and responsiveness. If the state of consciousness is undetermined, the seizure is classified under the parent term, that is, the main seizure class (focal seizure or seizure of unknown origin). Generalized seizures are grouped into absence seizures, generalized tonic–clonic seizures, and other generalized seizures, now including recognition of negative myoclonus as a seizure type. Seizures are described in the basic version as with or without observable manifestations, whereas an expanded version utilizes the chronological sequence of seizure semiology. This updated classification comprises four main classes and 21 seizure types. Special emphasis was placed on ensuring translatability into languages beyond English. Its aim is to establish a common language for all health care professionals involved in epilepsy care, from resource‐limited areas to highly specialized centers, and to provide accessible terms for patients and caregivers.
Top Cited PapersOpen AccessUpdated classification of epileptic seizures: Position paper of the International League Against Epilepsy
The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework established in 2017. This revision, informed by the implementation experience, involved a working group appointed by the ILAE Executive Committee. Comprising 37 members from all ILAE regions, the group utilized a modified Delphi process, requiring a consensus threshold of more than two thirds for any proposal. Following public comments, the Executive Committee appointed seven additional experts to the revision task force to address and incorporate the issues raised, as appropriate. The updated classification maintains four main seizure classes: Focal, Generalized, Unknown (whether focal or generalized), and Unclassified. Taxonomic rules distinguish classifiers, which are considered to reflect biological classes and directly impact clinical management, from descriptors, which indicate other important seizure characteristics. Focal seizures and those of unknown origin are further classified by the patient's state of consciousness (impaired or preserved) during the seizure, defined operationally through clinical assessment of awareness and responsiveness. If the state of consciousness is undetermined, the seizure is classified under the parent term, that is, the main seizure class (focal seizure or seizure of unknown origin). Generalized seizures are grouped into absence seizures, generalized tonic–clonic seizures, and other generalized seizures, now including recognition of negative myoclonus as a seizure type. Seizures are described in the basic version as with or without observable manifestations, whereas an expanded version utilizes the chronological sequence of seizure semiology. This updated classification comprises four main classes and 21 seizure types. Special emphasis was placed on ensuring translatability into languages beyond English. Its aim is to establish a common language for all health care professionals involved in epilepsy care, from resource‐limited areas to highly specialized centers, and to provide accessible terms for patients and caregivers.
- Open Access
- 31 July 2023
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 39 (3)
Aspectos electroclínicos de la epilepsia temporal mesial
Introducción: la epilepsia del lóbulo temporal mesial se considera la más frecuente de las epilepsias focales, con signos y síntomas característicos que ayudan a definir su diagnóstico. Contenidos: dentro de su historia natural, las crisis pueden iniciar en los primeros años de vida, usualmente como episodios febriles con un periodo de remisión, para reaparecer en la adolescencia o en el adulto joven. La presentación electroencefalográfica tiene un patrón característico, con aparición de puntas y ondas agudas interictales en la región temporal anterior, por lo general unilaterales, y con actividad ictal generalmente theta en la misma localización. La causa más frecuente es la esclerosis del hipocampo. El tratamiento con medicamentos anticrisis puede controlar la epilepsia, aunque algunos casos pueden evolucionar a la farmacorresistencia, en la cual la cirugía de epilepsia está indicada, y tiene buenos resultados. Conclusiones: esta revisión se centra en la descripción de las características electroclínicas de la epilepsia temporal mesial, para hacer un diagnóstico temprano e iniciar un tratamiento adecuado, a efectos de lograr un mejor pronóstico y una mejor calidad de vida para los pacientes con epilepsia y sus familiares.
- 31 July 2023
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 39 (3)
Open AccessAspectos electroclínicos de la epilepsia temporal mesial
Introducción: la epilepsia del lóbulo temporal mesial se considera la más frecuente de las epilepsias focales, con signos y síntomas característicos que ayudan a definir su diagnóstico. Contenidos: dentro de su historia natural, las crisis pueden iniciar en los primeros años de vida, usualmente como episodios febriles con un periodo de remisión, para reaparecer en la adolescencia o en el adulto joven. La presentación electroencefalográfica tiene un patrón característico, con aparición de puntas y ondas agudas interictales en la región temporal anterior, por lo general unilaterales, y con actividad ictal generalmente theta en la misma localización. La causa más frecuente es la esclerosis del hipocampo. El tratamiento con medicamentos anticrisis puede controlar la epilepsia, aunque algunos casos pueden evolucionar a la farmacorresistencia, en la cual la cirugía de epilepsia está indicada, y tiene buenos resultados. Conclusiones: esta revisión se centra en la descripción de las características electroclínicas de la epilepsia temporal mesial, para hacer un diagnóstico temprano e iniciar un tratamiento adecuado, a efectos de lograr un mejor pronóstico y una mejor calidad de vida para los pacientes con epilepsia y sus familiares.
- 1 August 2021
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 90, 117-122
Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis
- 1 August 2021
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 90, 117-122
Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis